Followers | 51 |
Posts | 1829 |
Boards Moderated | 0 |
Alias Born | 02/12/2022 |
Wednesday, September 21, 2022 4:52:10 AM
Aditxt, Inc., (Nasdaq: ADTX) (the “Company” or “Aditxt”), a biotech innovation company developing and commercializing technologies focused on monitoring and modulating the immune system, today announced the closing of its previously announced public offering of 3,333,333 shares of its common stock (or common stock equivalents in lieu thereof), together with warrants to purchase up to 3,333,333 shares of its common stock at a combined offering price to the public of $6.00 per share (or common stock equivalent) and associated warrant. The warrants have an exercise price of $6.00 per share, are exercisable immediately upon issuance, and will expire five years following the date of issuance.
Recent ADTX News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2024 08:24:20 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/20/2024 08:15:45 PM
- Evofem Biosciences Announces Financial Results for the First Quarter of 2024 • PR Newswire (US) • 05/15/2024 10:50:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 08:15:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 08:15:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:15:44 PM
- CORRECTING and REPLACING Aditxt Announces Pricing of $4.2 Million Private Placement Priced At-The-Market under Nasdaq Rules • Business Wire • 05/03/2024 06:14:00 PM
- Aditxt Announces Pricing of $4.2 Million Private Placement Priced At-The-Market under Nasdaq Rules • Business Wire • 05/03/2024 01:00:00 PM
- Aditxt Signs a Definitive Agreement to Acquire Appili Therapeutics Inc., Developer of a Biodefense Vaccine Funded by the U.S. Department of Defense (DoD) • Business Wire • 04/02/2024 12:30:00 PM
- Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023 • PR Newswire (US) • 03/27/2024 12:36:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 08:51:37 PM
- For Women Using GLP-1 Receptor Agonists who take Oral Birth Control Pills, Hormone-Free Phexxi Contraceptive Gel is a Logical Solution to Help Prevent Unintended Pregnancy • PR Newswire (US) • 03/07/2024 12:54:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 03/04/2024 10:27:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 10:24:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 09:01:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:01:59 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 02/22/2024 10:21:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 09:30:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:30:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:30:52 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/14/2024 02:26:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2024 09:31:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 09:30:11 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 02/02/2024 09:28:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 09:26:13 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM